Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer

Predictive Factors of Survival With and Without Repetition With 5 and 10 Years Curative Post-oesophagectomy for Cancer of the Oesophagus

NCT03410758 ·Status: COMPLETED

Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal Cancer

NCT01673607 ·Status: UNKNOWN ·Phase: PHASE2

ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases

NCT05787197 ·Status: RECRUITING

Circulating Tumor Cells in mCRC for Liver Resection

NCT03295591 ·Status: UNKNOWN

Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer

NCT05717751 ·Status: COMPLETED

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

NCT06967961 ·Status: RECRUITING ·Phase: NA

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

NCT03347162 ·Status: ACTIVE_NOT_RECRUITING

Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs

NCT02630654 ·Status: COMPLETED

Micrometastasis in Gastrointestinal Cancer

NCT01919151 ·Status: UNKNOWN

Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer

NCT02872779 ·Status: COMPLETED ·Phase: NA

Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer

NCT02355353 ·Status: UNKNOWN ·Phase: NA

The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line

NCT03205735 ·Status: UNKNOWN

Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab

NCT00491140 ·Status: COMPLETED

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

NCT06404593 ·Status: COMPLETED

Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer

NCT01527396 ·Status: COMPLETED

RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer

NCT02502656 ·Status: UNKNOWN

Effectiveness of Managing Suspected Metastasis and Progress Using Plasma D-dimer Testing in Gastric Cancer Patients

NCT04953585 ·Status: COMPLETED

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

NCT03364621 ·Status: ACTIVE_NOT_RECRUITING

Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer

NCT06135571 ·Status: RECRUITING

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

NCT02598219 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours

NCT03328065 ·Status: TERMINATED

Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer

NCT05572151 ·Status: COMPLETED

Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras

NCT01651013 ·Status: UNKNOWN

Predictors of Recurrence for High Risk Endometrial Cancer Patients

NCT04412902 ·Status: COMPLETED

Next Generation " Pre-clinical Model for Colorectal Cancer Metastases and Hepatocellular Carcinomas

NCT05384184 ·Status: COMPLETED